Autoliv and RS Taichi Partner to Advance Motorcycle Rider Protection with an Airbag Vest
STOCKHOLM, March 24, 2026 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV and SSE:…
![Fractal’s Climate Action Progress Recognized: 2025 [CDP] ‘B’ Rating Highlights Governance and Measurable Action](https://i0.wp.com/edge.prnewswire.com/c/img/favicon.png?w=420&resize=420,280&ssl=1 "Fractal’s Climate Action Progress Recognized: 2025 [CDP] ‘B’ Rating Highlights Governance and Measurable Action")
Fractal’s Climate Action Progress Recognized: 2025 [CDP] ‘B’ Rating Highlights Governance and Measurable Action
MUMBAI, India, March 24, 2026 /PRNewswire/ -- Fractal (www.fractal.ai), a publicly listed…
IMG Travel Outlook Survey Reveals 2026 Top Destinations and Rising Use of AI in Trip Planning
INDIANAPOLIS, March 24, 2026 /PRNewswire/ -- IMG has released the results of…
L&G and Manulife Wealth & Asset Management Announce Strategic Global Partnership
LONDON and TORONTO, March 24, 2026 /PRNewswire/ -- L&G and Manulife Wealth &…
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
Expanded treatment and visualization capabilities within posterior care workflows: ICGA for ZEISS…
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…
Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials
New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent…
HERE Technologies joins DCSA+ as first mapping and location intelligence partner advancing digital standards in container trade
Amsterdam – HERE Technologies, the leading mapping and location data platform, today announced…
Aptia and UST Earn ISG Paragon Award for Transformative Partnership
Partnership paves the way for disrupting traditional QA modelsBENGALURU, India and LONDON,…
Press Release: Sanofi and Regenerons Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine…
